McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access
McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access to the complete patient record. The goal behind the acquisition is to consolidate the technologies needed to automate and streamline workflow along every step of the diagnostic process from the time a test is ordered until the image is interpreted and the results are distributed to the referring physician, according to the company. The acquisition boosts McKesson's customer base to more than 500 installations. A.L.I. will be known as the McKesson Medical Imaging Group. Its employees will remain in the Vancouver, BC, location.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.